Cargando…

SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-induced infection, the cause of coronavirus disease 2019 (COVID-19), is characterized by unprecedented clinical pathologies. One of the most important pathologies, is hypercoagulation and microclots in the lungs of patients. Here we study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grobbelaar, Lize M., Venter, Chantelle, Vlok, Mare, Ngoepe, Malebogo, Laubscher, Gert Jacobus, Lourens, Petrus Johannes, Steenkamp, Janami, Kell, Douglas B., Pretorius, Etheresia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2021
Materias:	Diagnostics & Biomarkers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380922/ https://www.ncbi.nlm.nih.gov/pubmed/34328172 http://dx.doi.org/10.1042/BSR20210611

Ejemplares similares

TEG(®), Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy
por: Laubscher, Gert Jacobus, et al.
Publicado: (2021)

Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system
por: Kruger, Arneaux, et al.
Publicado: (2022)

Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report
por: Pretorius, Etheresia, et al.
Publicado: (2020)

Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes
por: Grobler, Corlia, et al.
Publicado: (2020)

Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
por: Pretorius, Etheresia, et al.
Publicado: (2021)

Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model
por: Turner, Simone, et al.
Publicado: (2023)

Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19
por: Venter, Chantelle, et al.
Publicado: (2020)

A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
por: Kell, Douglas B., et al.
Publicado: (2022)

Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC)
por: Pretorius, Etheresia, et al.
Publicado: (2022)

Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation
por: Page, Martin J., et al.
Publicado: (2019)

The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Nunes, Jean M., et al.
Publicado: (2022)

The Deleterious Effects of Impaired Fibrinolysis on Skeletal Development Are Dependent on Fibrin(ogen), but Independent of Interlukin-6
por: Cole, Heather A., et al.
Publicado: (2021)

Detection of Citrullinated Fibrin in Plasma Clots of Rheumatoid Arthritis Patients and Its Relation to Altered Structural Clot Properties, Disease-Related Inflammation and Prothrombotic Tendency
por: Bezuidenhout, Johannes A., et al.
Publicado: (2020)

Thrombin–Fibrinogen In Vitro Flow Model of Thrombus Growth in Cerebral Aneurysms
por: Ngoepe, Malebogo N., et al.
Publicado: (2021)

Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains
por: Pretorius, Etheresia, et al.
Publicado: (2017)

To What Extent Are the Terminal Stages of Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome Actually Driven by a Prion/Amyloid Form of Fibrin?
por: Kell, Douglas B., et al.
Publicado: (2018)

Gingipain R1 and Lipopolysaccharide From Porphyromonas gingivalis Have Major Effects on Blood Clot Morphology and Mechanics
por: Nunes, J. Massimo, et al.
Publicado: (2020)

Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities
por: Pretorius, Etheresia, et al.
Publicado: (2017)

MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023)

Correlative Light-Electron Microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson’s Disease, Alzheimer’s Disease and Type 2 Diabetes Mellitus
por: de Waal, Greta M., et al.
Publicado: (2018)

Fibrin(ogen) mediates acute inflammatory responses to biomaterials
Publicado: (1993)

Fibrin(ogen) in human disease: both friend and foe
por: Vilar, Rui, et al.
Publicado: (2020)

Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges
por: Gaule, Thembaninkosi G., et al.
Publicado: (2021)

Thrombin–Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases
por: Wen, Tingting, et al.
Publicado: (2023)

Iron Dysregulation and Dormant Microbes as Causative Agents for Impaired Blood Rheology and Pathological Clotting in Alzheimer’s Type Dementia
por: Pretorius, Lesha, et al.
Publicado: (2018)

Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease
por: Pretorius, Etheresia, et al.
Publicado: (2018)

The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia
por: Pretorius, Etheresia, et al.
Publicado: (2018)

No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases
por: Kell, Douglas B., et al.
Publicado: (2018)

The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
por: Kell, Douglas B., et al.
Publicado: (2022)

Psoriatic disease is associated with systemic inflammation, endothelial activation, and altered haemostatic function
por: Visser, Maria J. E., et al.
Publicado: (2021)

The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression
por: Kołodziejczyk, Joanna, et al.
Publicado: (2013)

The Role of Microclot Formation in an Acute Subarachnoid Hemorrhage Model in the Rabbit
por: Andereggen, Lukas, et al.
Publicado: (2014)

Anticoagulants and Immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS
por: Turi, S, et al.
Publicado: (2020)

Individuality, phenotypic differentiation, dormancy and ‘persistence’ in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology
por: Kell, Douglas, et al.
Publicado: (2015)

A Bacterial Component to Alzheimer’s-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease
por: Pretorius, Etheresia, et al.
Publicado: (2016)

Is Porphyromonas gingivalis involved in Parkinson’s disease?
por: Olsen, Ingar, et al.
Publicado: (2020)

Spatial Distribution of Factor Xa, Thrombin, and Fibrin(ogen) on Thrombi at Venous Shear
por: Berny, Michelle A., et al.
Publicado: (2010)

Profound Morphological Changes in the Erythrocytes and Fibrin Networks of Patients with Hemochromatosis or with Hyperferritinemia, and Their Normalization by Iron Chelators and Other Agents
por: Pretorius, Etheresia, et al.
Publicado: (2014)

Iron-Induced Fibrin in Cardiovascular Disease
por: Lipinski, Boguslaw, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8vtmamjepv04ja04vksg41u7f7